TABLE 1.
Participant demographics, symptoms and signs, and coinfection data for C. trachomatis LH-POCT, Xpert CT/NG, and discrepant resultsa
| Demographics | Total (N = 327) (%) | C. trachomatis positive (N = 55) (%) | Discrepants (N = 7) | No. of discrepant results for: |
|
|---|---|---|---|---|---|
| C. trachomatis-positive LH-POCT | C. trachomatis-positive Xpert | ||||
| Age, in yr | |||||
| 18–24 | 70 (21.41) | 16 (22.86) | 1 | 0 | 1 |
| 25–30 | 101 (30.89) | 18 (17.82) | 2 | 1 | 1 |
| 31–40 | 144 (44.04) | 21 (14.58) | 4 | 2 | 2 |
| >40 | 12 (3.67) | 0 (0) | 0 | 0 | 0 |
| Ethnicity | |||||
| iTaukei Fijian | 184 (56.27) | 44 (23.91) | 5 | 3 | 2 |
| Indo-Fijian | 90 (27.52) | 2 (2.22) | 1 | 0 | 1 |
| Other | 53 (16.21) | 9 (16.98) | 1 | 0 | 1 |
| Clinic | |||||
| Women's wellness health clinic | 245 (74.92) | 40 (16.33) | 6 | 3 | 3 |
| Reproductive health clinic | 5 (1.53) | 1 (20.00) | 0 | 0 | 0 |
| University clinic 1 | 30 (9.17) | 6 (20.00) | 1 | 0 | 1 |
| University clinic 2 | 16 (4.89) | 5 (31.25) | 0 | 0 | 0 |
| Outreach clinics | 12 (3.67) | 0 (0.00) | 0 | 0 | 0 |
| Valelevu health clinic | 19 (5.81) | 3 (15.79) | 0 | 0 | 0 |
| Asymptomatic | 123 (37.61) | 22 (17.89) | 0 | 0 | 0 |
| Symptomatic | 200 (61.16) | 33 (16.50) | 7 | 3 | 4 |
| Missing | 4 (1.22) | 0 (0) | 0 | 0 | 0 |
| Symptoms | |||||
| Dysuria | 36 | 7 | 0 | 0 | 0 |
| Urgency | 32 | 7 | 1 | 1 | 0 |
| Frequency | 37 | 11 | 1 | 1 | 0 |
| Hematuria | 8 | 1 | 0 | 0 | 0 |
| Lower abdominal pain | 93 | 16 | 1 | 1 | 0 |
| Dyspareunia | 45 | 9 | 1 | 0 | 1 |
| Bleeding with intercourse | 24 | 4 | 0 | 0 | 0 |
| Cramping | 51 | 9 | 1 | 0 | 1 |
| Vaginal discharge | 85 | 14 | 2 | 0 | 2 |
| Missing | 4 | 0 | 0 | 0 | 0 |
| No signs | 163 (50.46) | 23 (14.11) | 4 | 1 | 3 |
| Signs | 160 (49.54) | 32 (20.00) | 3 | 2 | 1 |
| Missing | 4 (1.22) | 0 (0) | 0 | 0 | 0 |
| Signs | |||||
| Cervical discharge | 95 | 21 | 0 | 0 | 0 |
| Vaginal discharge | 116 | 26 | 2 | 2 | 0 |
| Both | 60 | 15 | 1 | 0 | 1 |
| Cervical motion tenderness | 22 | 7 | 0 | 0 | 0 |
| Missing | 4 | 0 | 0 | 0 | 0 |
| No coinfection | 229 (70.03) | 32 (13.97) | 5 | 3 | 2 |
| Coinfection | 98 (29.97) | 23 (23.47) | 2 | 0 | 2 |
| Any coinfections | |||||
| N. gonorrhoeae | 15 | 11 | 0 | 0 | 0 |
| T. vaginalis | 15 | 3 | 0 | 0 | 0 |
| Candida | 31 | 2 | 0 | 0 | 0 |
| BV | 55 | 14 | 2 | 0 | 2 |
| ≥2 coinfections | 17 | 6 | 0 | 0 | 0 |
a
Because a participant may have more than one symptom, sign, or coinfection, the total per column may be more than 327.